LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway

Pancreatic ductal adenocarcinoma (PDAC) is one of most lethal cancers and is projected to be the second leading cause of cancer deaths in the United States by 2030. The lack of effective treatment and increased incidence in PDAC encourage a deeper knowledge of PDAC progression. By analyzing a long n...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ming, Cui, Ran, Ye, Lunhe, Wang, Yongkun, Wang, Xujing, Zhang, Qiqi, Wang, Kaijing, Dong, Chunxiu, Le, Wenjun, Chen, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413680/
https://www.ncbi.nlm.nih.gov/pubmed/34513310
http://dx.doi.org/10.1016/j.omtn.2021.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413680/
https://www.ncbi.nlm.nih.gov/pubmed/34513310
http://dx.doi.org/10.1016/j.omtn.2021.07.004

Ejemplares similares